Amitriptyline vs GON and SON Blocks in Migraine

• Status: Recruiting
• Trial end date: 2022-02-01
• Target enrollment: 0
• Participant gender: All

Summary

Comparison of efficacy and safety of amitriptyline and nerve blocks

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Dr. Lutfi Kirdar Kartal Training and Research Hospital; Dr.Lütfi Kırdar Kartal Eğitim ve Araştırma Hastanesi
• Treatments: Amitriptyline; Amitriptyline, perphenazine drug combination; Lidocaine

Criteria

Inclusion Criteria:

• Diagnosed with migraine according to ICHD-3

Exclusion Criteria:

• Being over 50 years or under 18 years

• Malignancy and other systemic diseases